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BACKGROUND: Routine numeric screening for pain is
widely recommended, but its association with overall
quality of pain care is unclear.
OBJECTIVE: To assess adherence to measures of pain
management quality and identify associated patient
and provider factors.
DESIGN: A cross-sectional visit-based study.
PARTICIPANTS: One hundred and forty adult VA out-
patient primary care clinic patients reporting a numeric
rating scale (NRS) of moderate to severe pain (four or
more on a zero to ten scale). Seventy-seven providers
completed a baseline survey regarding general pain
management attitudes and a post-visit survey regarding
management of 112 participating patients.
MEASUREMENT AND MAIN RESULTS: We used chart
review to determine adherence to four validated process
quality indicators (QIs) including noting pain presence,
pain character, and pain control, and intensifying
pharmacological intervention. The average NRS was
6.7. Seventy-three percent of charts noted the presence
of pain, 13.9% the character, 23.6% the degree of
control, and 15.3% increased pain medication prescrip-
tion. Charts were more likely to include documentation
of pain presence if providers agreed that “patients want
me to ask about pain” and “pain can have negative
consequences on patient’s functioning”. Charts were
more likely to document character of pain if providers
agreed that “p a t i e n t sa r ea b l et or a t et h e i rp a i n ”.
Patients with musculoskeletal pain were less likely to
have chart documentation of character of pain.
CONCLUSIONS: Despite routine pain screening in VA,
providers seldom documented elements considered
importanttoevaluationandtreatmentofpain.Improving
pain care may require attention to all aspects of pain
management, not just screening.
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INTRODUCTION
Pain is a common debilitating condition. Approximately 20% of
patients and 25% to 50% of community-dwelling elders
experience chronic pain.
1,2Although many studies have iden-
tified under-treatment of pain,
1–3 few have examined why
providers vary in responding to patient-reported pain.
3,4 Such
information would help inform more successful approaches to
pain management.
In 2003, the Department of Veterans Affairs (VA) implemen-
ted the “5th vital sign”—a rating also known as the numeric
rating scale (NRS)
3,4 to assure routine pain assessment and
improve management.
3,5–9 The NRS asks veteran patients to
rate current pain from zero or “no pain” to ten or “worst
possible pain”.
3,6,7
Moderate to severe pain, measured by a score on the NRS
between four and ten, should typically trigger a comprehensive
pain assessment and prompt intervention.
5 However, one
study at a single VA medical center, found that routine pain
screening did not change provider medication management.
3
That study occurred soon after implementing the 5th vital
sign, using a pre-post design and did not examine the extent to
which providers utilized the NRS for pain evaluation and
management. This study builds on earlier work in developing
an assessment across multiple sites with established NRS
procedures and examines multiple processes of care, from
assessment of pain to treatment.
We examined indicators of four key processes of pain
evaluation and management in a regional cohort of facilities
where routine pain screening was implemented during the last
10 years. We estimated adherence to these indicators and
examined patient and provider factors associated with these
processes of care.
METHODS
Subjects and Setting
The Helping Veterans Experience Less Pain (HelpVets) study is
a VA-funded cross-sectional cohort study designed to evaluate
adherence to basic pain care management. We conducted the
study from March 2006 to March 2007 in primary care,
oncology, women’s health and cardiology outpatient clinics at
two VA hospitals and six associated clinics in the VA Greater
Los Angeles Healthcare System.
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900Participants: Patients
We approached patients in the waiting areas of the outpatient
study clinics; patients meeting inclusion criteria were invited
to participate. Eligible patients were seen by participating
providers, had vital signs taken during their visit, passed a
brief cognitive screening test, spoke English, had intact
hearing, had not previously participated and agreed to have
their medical records reviewed. To assure an adequate number
of subjects with possible pain-related conditions, we included
all patients who reported fair or poor health, and every other
patient who reported good (or better) health. In total, 6,138
patients were approached. Of those approached, 862 refused
screening; 4,337 were ineligible (2,265 had not yet had vital
signs taken, 942 had not visited a provider, 310 visited non-
participating clinics, 171 exhibited cognitive problems, 103
visited non-participating providers, 61 previously participated,
49 were hearing impaired). Of the remaining 939 eligible
patients, 650 completed the patient baseline survey yielding a
69.2% response rate. Further details of the methods are
elsewhere.
6 The present analysis includes the 140 patients
reporting moderate to severe pain (an NRS of four or
higher).
3,5,7–9
Patient Baseline Survey. The baseline survey asked patients
about the degree to which pain was discussed during the
nurse and provider visits, current treatment regimens and
general quality of life issues.
Participants: Providers
Provider Baseline Survey. We asked all providers (n=260) in
relevant clinics to complete a baseline survey about attitudes,
beliefs, and practices prior to patient interviews. Of those
approached, 209 (74%) completed surveys. This study
includes 77 providers (45 staff physicians, nine fellows, five
house staff, 14 nurse practitioners and four physician
assistants) who cared for 140 patients in the analytic sample.
Of the 77 providers, 57% had one patient, 17% had two
patients, 14% had three patients, 10% had four patients and
1% had five patients.
Provider Post-visit Survey. After the patient visit, providers
were asked to complete a post-visit survey that assessed
provider’s perception of, and discussion about patient’s pain
as well as whether they initiated or intensified a pharma-
cological intervention. If applicable, we queried about reasons
for not changing treatment. Sixty-five of the 77 providers
completed post-visit surveys for the 140 patients in the initial
analytic sample, yielding valid post-visit provider data for 112
patients.
Additional Data Sources
Medical Record Review. Data elements for all four indicators
were abstracted from clinic notes in the VA’s electronic medical
record (Computerized Patient Record System or CPRS) by one,
experienced abstractor. To assure accuracy, the abstractor
reviewed questionable records with physician investigators.
Pharmacy Data. We obtained pharmacy data from the regional
data warehouse to supplement medical record estimates of
pain regimen alteration. We identified pain medications
dispensed within 90 days before and 90 days after each
study visit. Of the 747 total prescriptions dispensed, 282
prescriptions were 24 unique agents used to treat pain
including: acetaminophen, non-steroidal anti-inflammatory
drugs (NSAIDs), anti-seizure medicines used for analgesia,
opioids and topical analgesics. A Ph.D. data abstractor
characterized each prescription for each patient based on days
of supply, dose, instructions and frequency of dispensing
during the study. Increases in any of these factors resulted in
an “increase” rating, while a decrease in any factors received a
“decrease” rating. Prescriptions that remained consistent
received a “no change” rating. After reviewing all medicines,
each patient received an overall rating of “increase”, “decrease”,
or “no change”. A physician over-read 10% of all characteristics
and to resolve any clinical difficulties that the abstractor faced.
Of note, the available pharmacy data did not include non-VA
pharmaceutical use.
Conceptual Framework
The Theory of Planned Behavior by Azjen and Fishbein
explores the relationship between beliefs, attitudes, intentions
and subsequent behavior.
10 It postulates that a person’s
attitude toward performing a behavior influences intent as do
beliefs about the behavior by persons(s) who are important to
the individual.
11–13 This theoretical model helps explain how
provider beliefs, attitudes, and intentions may be important
in understanding feelings about the NRS and responses to a
moderate to severe pain rating. Provider attitudes toward a
behavior (shaped by beliefs), subjective norms (determined by
social standards), and provider perceived behavioral control
about documenting and treating pain were all key constructs
in evaluating determinants of pain management. However, it
was infeasible to collect some variables in the framework and
they were omitted from this analysis.
Measures: Dependent Variables (Quality
Indicators)
The four quality indicators (QIs) evaluating pain assessment
and management were adapted from the Assessing Care of
Vulnerable Elders (ACOVE)
14–18 and Quality Assessment
(QA) Tools measurement sets.
19,20 Specifically, the four stem
from the following recommendations for patients with
moderate to severe pain on the NRS: 1. evaluate the presence
or absence of pain; 2. evaluate the character of the pain; 3.
note the degree of pain control; and 4. initiate or intensify pain
treatment.
We assessed the degree to which providers adhered to each
individual quality indicator, leaving interpretation deliberate-
ly liberal to meet the intent of the indicators. For example,
any documentation of pain (or absence of pain) in the
progress note met the first quality indicator. The character
o fp a i ni n c l u d e dm a n yt e r m ss u c ha st y p e( e . g . ,t h r o b b i n g ,
intermittent), location, and/or mitigating or worsening fac-
tors. General statements about improvement or stability of
pain symptoms satisfied evaluation of pain control. Pharmacy
prescriptions were carefully examined for initiation or inten-
sification of pain management; we also assessed progress
notes for advice on current prescriptions or over-the-counter
medication(s).
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Selection of independent variables representing provider and
patient attitudes and demographics was guided by: 1. Litera-
ture review
1,3,13,21–24; 2. Conceptual framework
10–13; and 3.
Experts in palliative care and research.
19,20,25–30
The independent variables included:
& Baseline Provider Variables
Provider attitudes toward pain management were mea-
sured by seven items with 5-point Likert response scales
(strongly disagree to strongly agree): “patients are able to
rate their own pain intensity on the 0–10 scale”, “0–10
pain ratings by nurses accurately reflect the patient’s pain
intensity”, “my patients want me to ask about their pain
problems”, “pain medication should be given when pain is
severe”, “pain can have negative consequences for a
patient’s functioning”, “when reviewing patient’sv i t a l
signs, I pay attention to their 0–10 pain score”,a n d
“patients are more satisfied when I address their pain
concerns.” We also queried about the percentage of
provider’s outpatients with painful conditions and collected
information about the provider’sr a c e .
& Baseline patient variables
We controlled for substance abuse or musculoskeletal
pain, and for patient age and race.
& Post-visit provider variables
The post-visit analytic variables included dichotomous
questions (yes or no responses) that asked whether during
the visit the provider: (1) noticed the nurse’s NRS; (2)
thought the patient was in pain; (3) talked about the
symptom of pain; (4) had reasons for not discussing pain,
as applicable (four different reasons); and (5) reasons for
not initiating or intensifying treatment (five options).
Institutional Review Board (IRB) approvals were obtained by
the VA Greater Los Angeles Healthcare System and the VA Long
Beach Healthcare System.
Analysis
We performed weighted bivariate logistic regressions to mea-
sure associations of the provider baseline variables with the
four quality indicators. All associations with p-value <0.10 were
included in multivariate analyses. We employed weighted
logistic regressions fitting nested models by sequentially adding
blocks of variables in StataSE 10.0. In each model, we first
entered the block representing the provider attitude variables
because we felt those variables were, conceptually, the most
important for predicting the quality indicators. We then added a
second block containing variables for two diagnoses (substance
abuse and musculoskeletal pain), as these were previously
identified as potential barriers in responding to pain. Patient
and provider demographic variables (patient race and age,
provider race) were added into the model last. The nested
models were performed as a sensitivity analysis to confirm our
model. We report the “full” model containing all variables.
In addition, we examined whether there were differences in
provider reporting and medical record documentation by evalu-
ating the percent of patients who received initiation or intensifi-
cation of treatment (based on chart review) and compared that
information to responses on the provider post-visit survey.
All analyses were weighted for patient survey non-response
based on age, race, general health, cognition score, and
adjusted for over-sampling of persons in fair to poor health. No
adjustment for clustering by provider was needed given minimal
variation in the number of patients per provider, with 74% of
providers having one or two patients.
RESULTS
Most patient participants were non-Hispanic white (46.1%),
African American (28.2%), or Hispanic (19.0%). Their mean age
was 59.2 years and 95% were male. On chart review, 65
(46.1%) had a diagnosis of substance abuse and 90 (64.2%)
had a diagnosis of musculoskeletal pain. On average, providers
estimated that 40% of their patients had pain. Provider beliefs
regarding pain are presented in Table 1. Of the 140 patients
who reported moderate to severe pain, the average pain score
was 6.7. Table 2 presents scores for each quality indicator;
Table 3 presents multivariate analysis.
Presence of Pain Noted
Providers were more likely to document the presence of pain if
they believed that: “patients are able to rate their own pain
intensity” (OR=2.02, p=0.01), “patients want him/her to ask
about pain” (OR=3.49, p=0.01) or if “pain medications should
be given when pain is severe” (OR=3.17, p=0.01). Providers
were also more likely to document pain presence if they
perceived a “pain rating as an important vital sign” (OR=
1.82, p=0.01) and “patients were more satisfied when they
address pain concerns” (OR=2.41, p=0.02), but less likely to
document pain for patients with substance abuse history
(OR=.399, p=0.02). In multivariate analysis (Table 3), two
provider attitudes were significantly associated with the
notation of pain presence: “patients want me to ask about
pain” (OR=4.20, p=0.04) and “p a i nh a sn e g a t i v ec o n s e -
quences on patient functioning” (OR=7.10, p=0.01).
Character of Pain Noted
In bivariate analysis, documentation of pain character was
found less often for patients who had a diagnosis of musculo-
skeletal pain (OR=0.25, p=0.01). In multivariate analysis,
“patients are able to rate own pain intensity” was associated
Table 1. Provider Attitudes About Patients with Pain
a
% Providers whom strongly agree with: Percent (%)
Patients are able to rate their pain intensity 9.8
0–10 ratings by nurses accurately reflect patients pain
b 27.5
Patients want me to ask about their pain 33.0
Pain medicines should be given when pain is severe 48.0
Pain has negative consequences on patient functioning 54.6
Pain rating is an important part of vital signs 13.5
Patients are more satisfied when pain concerns
are addressed
34.9
a Respondents are 77 providers in reference to the 140 patient sample
b This rating reflects providers whom rated both “strongly agree” and
“agree”
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2.48, p=0.05); those with musculoskeletal pain were less likely
to have the character of pain documented (OR=0.22, p=0.05).
The model was significant (χ
2=29.12, p=0.01).
Degree of Pain Control Noted
In bivariate analyses, the following were associated with noting
degree of pain control: provider’s perception that patients could
“accurately rate their pain intensity” (OR=2.03, p=0.01), the
need for providing “pain medications when pain is severe” (OR=
2.83, p=0.01), pain having “negative consequences on patients’
functioning” (OR=3.75, p=0.01), and paying “attention to 0–10
pain scores when reviewing patient vital signs” (OR=1.82, p=
0.04). Patient age was inversely associated with documenting
pain control (OR=0.98, p=0.10). These relationships did not
persist in multivariate analyses.
Pain Treatment Initiated or Intensified
Performance on this indicator was not significantly associated
with any of the provider attitudes or other variables in either
bivariate or multivariate analyses.
Post-visit Survey
Providers completed at least part of the post visit survey
following 112 (80%) of patient visits. Providers reported they
noticed the NRS during 67% of visits and in 64% of visits
reported the patient was in pain.
While medical record and pharmacy data review found
documentation of treatment intensification in just 15% of
visits, providers self-reported initiating or intensifying treat-
ment at 48% of the visits. Thus, agreement between the two
sources was poor (kappa=0.076, 95%CI=−0.1, 0.25).
Providers gave various reasons for not initiating or intensi-
fying treatment for 40 such patients. The most common reason
was that “the patient preferred not to change his/her current
approach” (56%) followed by “everything has been done”
(34.7%), “patient not experiencing pain” (26.0%), “patient
misusing pain medication” (8.5%) and “patients not respond-
ing to previous treatments” (5.4%).
DISCUSSION
We found that among patients who reported moderate to
severe pain at an appointment, providers often noted the
presence of pain but did not clinically evaluate it further or
modify pharmacologic treatment. Provider attitudes were weak
predictors of adherence to quality indicators, although some
provider attitudes toward the NRS were correlated with QI
adherence.
Similar to prior studies,
3,6,25 our results question whether
the 5th vital sign has substantively improved pain assessment
and management. More notably, Mularski et al.
3 reported that
Table 2. Frequencies of Quality Indicators from Chart Review
When patient reports moderate to severe pain, was...
(N=140)
Yes (%)
The presence of pain noted? 102 (72.8)
The character of the pain noted? 19 (13.9)
The degree of pain control? 33 (23.6)
Treatment intensified or initiated? 21 (15.3)
Table 3. Nested Logistic Regressions to Predict Quality of Care Indicators
N=120
c Presence of
Pain
Character of
Pain
b
Degree of Pain
Control
Initiate/ Intensify
Treatment
Independent variables OR 95% CI OR 95% CI OR 95% CI OR 95% CI
“% Outpatients with pain” 0.99 1.01 1.00 0.99
0.97–1.02 0.98–1.04 0.98–1.03 0.97–1.03
“Patients are able to rate their own pain intensity” 1.58 2.48
a 1.78 1.93
0.79–3.12 1.02–6.08 0.80–3.94 0.85–4.38
“0–10 pain ratings by nurses accurately reflect patients pain intensity” 0.88 1.47 1.01 0.41
0.40–1.90 0.37–5.84 0.46–2.18 0.15–1.15
“Patients want me to ask about their pain problems” 4.20
a 2.53 0.66 0.59
1.09–17.13 0.68–9.38 0.21–2.07 0.19–1.81
“Pain medication should be given when pain is severe” 0.75 0.46 2.40 1.15
0.25–2.32 0.11–1.90 0.51–11.33 0.26–5.19
“Pain can have negative consequences for a patient’s functioning” 7.10
a 2.72 2.00 2.83
1.48–34.16 0.47–15.81 0.42–9.65 0.40–20.07
“When reviewing patients’ vital signs, I pay attention to 0–10 pain score” 1.51 0.61 1.77 1.13
0.77–2.94 0.18–2.07 0.92–3.40 0.59–2.17
“Patients more satisfied when address pain concerns” 0.43 0.80 0.37 0.46
0.12–1.55 0.15–4.30 0.12–1.14 0.16–1.35
Substance abuse 0.37 0.44 0.71 2.59
0.10–1.39 0.11–1.77 0.23–2.18 0.76–8.86
Musculoskeletal pain 1.21 0.23
a 1.87 0.42
0.35–4.12 0.05–.98 0.60–5.83 0.14–1.26
Patient race (white vs. others) 1.17 0.74 0.38 0.42
0.42–3.19 0.20–2.74 0.13–1.09 0.11–1.61
Patient age 0.98 1.01 0.97 1.01
0.91–1.05 0.95–1.07 0.93–1.01 0.99–1.05
Provider race (white vs. others) 1.69 0.42 1.28 0.45
0.49–5.82 0.06–2.92 0.37–4.42 0.12–1.72
aP-value for independent variable was p<0.05
bProbability for nested logistic regression statistically significant at p<0.05
cN is less than 140 because of missing data due to item-level non-response
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documentation or treatment intensification. Our results extend
previous work in three ways. First, our indicators were closely
adapted from ACOVE
14–18 and were subjected to a rigorous
development process. As such, the quality indicators allowed us
to more broadly measure processes of care (i.e., notation,
character and severity of pain). Second, Mularski et al.
3
conducted their study between 1999 and 2001, soon after the
institution of the NRS when providers were perhaps not familiar
with it. Our results, a decade later, suggest the screening tool
still has had limited impact on pain management. Third, our
work extends Mularski’s findings from a single VA site to
multiple sites.
Why the 5th vital sign has not produced more substantive
improvements is unclear. One possibility is the NRS does not
accurately represent pain levels or that providers do not
perceive it as accurate, and hence do not act based on the
rating scale. Indeed, 12% of providers disagreed or strongly
disagreed that “p a t i e n t sa r ea b l et or a t et h e i ro w np a i n
intensity on the 0–10 scale” (Table 1), suggesting concern with
the tool. Another possibility is that providers do not approach
pain evaluation uniformly. Chronic pain patients are vexing for
many providers
22–26 and the subjective nature of pain likely
adds to variance in addressing it. While rating pain numeri-
cally may create a standard measurement, it may not yield a
standardized approach to its subsequent evaluation and
management. Further research is needed on variations in pain
management but, in the meantime, providers and patients
might benefit from clinical decision support tools (e.g., clinical
reminders) within CPRS.
Measuring pain management poses unique methodological
challenges. Chart review may not be optimal (for example,
pharmacy records may not represent all provider actions),
though it remains the current gold standard. However, our
study looked for new or adjusted prescriptions within 90 days
of a visit to evaluate for initiation or intensification. Even so,
our results identified a divergence between providers’ self-
described actions and pharmacy records. This could point to
inaccurate information reflected in the pharmacy records,
although this is unlikely within the VA. However, our pharma-
cy data did not include non-VA prescriptions and this may
have importance since some patients, particularly those who
have an $8 per month co-payment for each prescription,
purchase medications privately. Several non-pharmaceutical
intensification strategies were reported by patients to be useful
(e.g., physical therapy, ice). Also, at times, initiation or
intensification may not have been the most appropriate clinical
action. When intensification did not occur at the visit,
providers most commonly reported that patient preference
was not to change treatment, “everything had been done”,o r
the patient was not experiencing pain. Furthermore, visit
based quality indicators may not be accurate proxies for
measuring the quality of pain care at a single visit. Future
research could consider longitudinal information to better
understand factors influencing pain management. In addition,
qualitative interview of providers may help to understand
adherence to and predictors of the quality indicators. We
examined only VA outpatients, limiting generalizability to other
populations and healthcare systems. However, the VA is a
leader in chronic care quality measurement
2,3,17,20,23,24 and
our study sites implemented routine pain screening a decade
ago suggesting our findings represent a ‘best case scenario.’
Our study provides greater understanding of how the 5th
vital sign and providers’ attitudes toward pain influence the
quality of pain care. We found that simply implementing the
NRS does not necessarily improve subsequent pain evaluation
and management, as measured by four standardized quality
indicators. Future research should examine what additional
provider factors are associated with meeting the quality
indicators and consider assessing non-pharmacologic inter-
ventions. Focused research could include bolstering the 5th
vital sign beyond categorizing pain at one point in time; for
example, additional screening question(s)
31–33 might address
whether a patient’s current regimen provides sufficient pain
control. Whether adding such screening questions would
improve pain management is unknown, but it appears that
using the NRS scale alone does not guarantee high quality
pain management.
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